The awards were announced during a virtual evening event last Saturday called 'This Is Us 2020', which started with a presentation by Dr Jane Goodall DBE, followed by the award presentation by the BVNA’s Junior Vice President, Jo Oakden.
Christine Robinson won the St Francis Award, which is given to the nurse who has gone above and beyond for their team, for their patients and for the veterinary nursing profession over the past 12 months.
Christine said: "I am delighted to have won this award, and very surprised! In my very long and diverse career, I have never won an award at all. It’s been lovely to have been acknowledged by others and seen as a role model, and for my nursing to be recognised."
Bethany Scott won the Help in the Community Award, which is for a nurse who has gone above and beyond to help animal owners and/or their clinical teams during the Covid-19 pandemic.
Bethany said: “I am absolutely shocked and I really wasn’t expecting this! Thank you to those who nominated me and congratulations to everyone else.”
Last but by no means least, Courtney Scales won the VNJ Writer of the Year Award for writing articles which have encouraged positive change, discussions or improved clinical standards in practice.
Courtney said: "This has made my entire year! I am just super super proud, having presented the topic at Congress last year and then going on to write the articles. I really think I have changed quite a few nurses’ perceptions, protocols and patience, and it’s just so exciting."
Jo Oakden said: “It was fantastic to see all the worthy nominees and finalists for our new BVNA awards and Hills and Blue Cross awards.
"The high standards, dedication and resilience of our profession was demonstrated with all of our nominees and winners of the awards, showing they can adapt and overcome to be champions in our profession to help educate and inspire those within and outside of our profession.
"It was a huge honour to be able to present these awards and still keep the celebratory feel in these unusual times. A huge congratulations to all our winners.”
Hear hear!
Omniotic combines three ingredients to remove ear wax and debris: a detergent, a solvent and an emulsifier. It also contains Octoxynol-9, lactic acid, salicylic acid and parabens, which Vita says have anti-fungal, anti-viral and anti-bacterial properties.
The product is sold in 120ml bottles with a transparent flexible tip designed to be comfortable even in stenosed, tender ear canals.
Omniotic can be used for regular daily cleaning, especially in predisposed breeds such as spaniels and lop-eared rabbits where ear conformation increases the risk of ear disease.
The product can also be used alongside other antibiotics or anti-fungal medications, something which Vita highlights as being especially important in rabbits, the ear canals of which are less prone to inflammation and stenosis, and for which topical treatment can be very effective.
Tara Evans, RVN and sales manager said: "Omniotic is an ear cleaner for dogs, cats and rabbits which combines features to meet the needs of owners and vets at the same time. The feedback from our customers is very positive; they are finding the soft, flexible applicator tip is easy to use and well tolerated. The unique combination of ingredients and the multi-species use means Omniotic can be used to support ear health across a wide variety of indications."
For more information and for the latest promotional offers, contact Tara Evans, via email: info@vitaanimalhealth.com, or telephone: 01256 591032.
British shoppers are not losing sleep over the quality of their meat, milk and eggs - at least as far as animal medicines are concerned. They know farmers and their vets do a good job, and trust them to use medicines responsibly, for the health of food producing animals. They do not feel the need to actively seek information about their use. While one fifth have no concerns at all about how their food is produced, factory hygiene and animals' living conditions are at the top of consumers' lists of priorities as far as food production from farm animals is concerned.
These were the conclusions of a recent survey, commissioned by the National Office of Animal Health (NOAH), which examined consumer attitudes toward animal medicines. A total of 1,000 adults, from a range of socio-economic groups across Great Britain, took part.
The survey found that animal medicines and vaccinations are of little concern to consumers, although there is a relatively high level of awareness among shoppers that they are used.
In total, 58% of consumers are aware that farm animals are vaccinated; 58% are aware that farm animals are treated with medicines; and 50% of consumers are aware that farm animals are given preventative medicines. Just 24% of those surveyed were not aware of any medicine use.
The research indicated that, for some shoppers, this lack of awareness was related to a general lack of interest in how food is produced. They make their purchase decisions based mainly on price and appearance.
For those shoppers who do have concerns, hygiene standards in food processing factories and animal living conditions on farms are the most important. Hygiene in factories is the primary concern cited by 22% of respondents, compared with just 4% citing animal vaccinations as their primary concern.
"These results are very encouraging for farmers, vets and the animal health industry alike: they indicate shoppers know they are using medicines responsibly and show a high level of trust by consumers in farmers, veterinarians and animal medicines. They also show that consumers are aware of the need for the careful and responsible use of animal medicines," said Phil Sketchley, Chief Executive of NOAH. "Consumers are reassured by the regulations that exist and the measures that farmers and the animal health industry take".
Flimabend is diluted into water and replaces the flock’s drinking water for a set period during the day.
The new 20g pack includes a post-prescription leaflet to help veterinary surgeons support clients in calculating the correct dose, based on the bodyweight of their flock. It also includes a measuring scoop to ensure accurate administration.
Flimabend is effective against the three key intestinal worms affecting chickens – Ascaridia (roundworm); Capillaria (hairworm) and Heterakis gallinarum, which can be a vector for Blackhead disease. No egg withdrawal period is required.
Charlotte Read, Krka's Key Account Manager – Farm said: “Poultry-rearing is on the increase in the UK, both at a commercial level and among the public. Recent figures suggest that more than one million UK households keep chickens, with the majority of domestic flocks comprising five laying hens and a cockerel1.
"A regular worming routine is, of course, essential for optimal flock health and ensuring ease of use in a worming product is the most effective way of ensuring compliance, especially among those keeping backyard chickens.
“As one of the first water-based worming products available for small flocks, Flimabend now offers an innovative presentation of Flubendazole which we believe offers a new level of convenience and flexibility.”
Krka is currently offering virtual ‘lunch and learns’ on the worming of backyard chickens. Contact your Krka Account Manager for more details.
Reference
A study published in Current Biology has demonstrated that there are remarkable similarities in the way that dog and human brains respond to sound, and that dog brains, like those of people, are also sensitive to acoustic emotional cues.
Lead by Attila Andics, researchers from MTA-ELTE Comparative Ethology Research Group in Hungary trained 11 dogs to lay motionless in an fMRI brain scanner. This made it possible to run the same neuroimaging experiment on both dog and human participants - something that had never been done before. They captured both dogs' and humans' brain activities while the subjects listened to nearly 200 dog and human sounds, ranging from whining or crying to playful barking or laughing.
The resultant scans showed that dog and human brains include voice areas in similar locations. Not surprisingly, the voice area of dogs responds more strongly to other dogs while that of humans responds more strongly to other humans.
The researchers also noted striking similarities in the ways the dog and human brains process emotionally loaded sounds. In both species, an area near the primary auditory cortex lit up more with happy sounds than unhappy ones. Andics says the researchers were most struck by the common response to emotion across species.
There were some differences, too: in dogs, 48% of all sound-sensitive brain regions respond more strongly to sounds other than voices. That's in contrast to humans, in which only 3% of sound-sensitive brain regions show greater response to nonvocal versus vocal sounds.
The researchers say that the findings suggest that voice areas evolved at least 100 million years ago, the age of the last common ancestor of humans and dogs. It also offers new insight into humans' unique connection with our best friends in the animal kingdom and helps to explain the behavioural and neural mechanisms that made this alliance so effective for tens of thousands of years.
Andics said: "This method offers a totally new way of investigating neural processing in dogs. At last we begin to understand how our best friend is looking at us and navigating in our social environment."
Photograph: Borbala Ferenczy. Dogs at the MR Research Centre (Budapest).
The campaign uses Pennies, the digital charitable giving system which invites you to make a small donation when you pay for something by debit or credit card.
For the last four years, Medivet clients have been invited to make a donation of 50p when paying their veterinary bill, and the millionth donation was made at Medivet 24 Hour Shrewsbury this week.
Medivet says the funds raised have played a crucial role in helping to protect the rhino - enabling Wilderness Foundation Africa's Forever Wild Rhino Protection Initiative to support these critically endangered species across a wide range of activities. This includes the treatment of poaching attack survivors plus the care and rehabilitation of orphaned baby rhinos.
In terms of prevention, thanks to Medivet client donations, two cold scent tracker dogs have been deployed – Ella and Ziggy – who work with anti-poaching units, while support has also been provided for intelligence-sharing amongst local law-enforcement agencies. Funds have additionally been deployed to help drive global awareness, provide community services as well as essential field-based veterinary equipment.
Dr John Smithers, Senior Partner and Project Co-ordinator for Medivet Saving the Rhino, said: "We could not be more grateful to our clients for all they have done to help the survival of this iconic species. Their incredible generosity - combined with the support of our colleagues and partners - has made a real difference in the fight against poaching and we want to thank our clients for every donation made."
In South Africa, the Medivet-supported efforts to reduce poaching are co-ordinated by Dr William Fowlds, a former Medivet employee, who added: "This is a truly remarkable milestone and we are overwhelmed by the kindness of Medivet and its clients. The money raised not only helps protect the rhinos but helps bring to justice those responsible for the destruction of these precious and innocent creatures."
Alison Hutchinson, CBE, CEO of Pennies said reaching 1m donations was a remarkable achievement: “Pennies is proud to support Medivet’s Saving the Rhino campaign, and it’s been so inspiring to see one million individual micro-donations made through the digital charity box over the past four years.
"From all at Pennies, thank you and congratulations to the Medivet team and their hugely generous clients for reaching this milestone, for challenging the rhino poaching crisis in South Africa, and proving that small change truly does add up to mean big things."
Three cheers from VetNurse.co.uk, too. That's a big achievement by Medivet for an important cause.
Carbodote Prime is the first activated charcoal product for cats and dogs to contain a cathartic, which speeds up intestinal transit time so that bound toxins are expelled more quickly.
Carbodote Repeat is for those situations where repeated administration of plain activated charcoal is needed due to the type of the toxin involved.
Carbodote Repeat can be administered to the patient every 4-6 hours over 24-48 hours.
Both products are presented as a ready-mixed, easy to swallow gel formulation, for less mess and reduced risk of aspiration.
TVM says the 60ml ‘dial and dispense’ syringes make administration easy for both veterinary staff and pet owners.
For more information, visit www.tvm-uk.com/carbodote or contact your Territory Manager.
The SPVS Salary Survey provides a benchmark of remuneration levels in the profession, including basic earnings, bonuses, dividends, overtime, accommodation, car allowances and pensions.
The main survey findings will be published in a report which will be shared with anyone who takes part and gives their email address at the end of the survey.
SPVS members will be given the full results with additional commentary and analysis.
The Association says all responses are treated as strictly anonymous and totally confidential, and thanks everyone in advance who decides to take part.
To take part, visit: https://spvs.org.uk/salary-survey-2021.
If you have any questions about the survey, email office@spvs.org.uk.
'Managing Veterinary Medicines' teaches safe and responsible use of veterinary medicines and medicine regulations.
RCVS Knowledge says it will also show you how to put systems in place that will reduce errors, improve patient outcomes and improve practice systems.
It's worth six hours of CPD.
The course has been produced in collaboration between RCVS Knowledge and the Veterinary Medicines Directorate (VMD), and includes a range of webinars, podcasts and articles.
Executive Director at RCVS Knowledge, Chris Gush said: “In England alone, more than 1,700 people die yearly because of medication errors.
"While we don't know the true figures in veterinary medicine, we do know that 30% of errors reported to the VDS's VetSafe system are due to medication errors.
“That's why we think it's vital to have good robust systems in place in the practice dispensary and to use QI tools like guidelines, protocols, and checklists.
CEO of the VMD, Abi Seager said: “Managing Veterinary Medicines will help teams comply with legislation as well as keep patients, team members and clients safe when prescribing and dispensing medicine.”
The course will also prepare practices for a VMD inspection or an RCVS Practice Standards Scheme assessment.
https://learn.rcvsknowledge.org
The campaign comes after the Association carried out a survey of 1000 of its members which found that 79% had been affected or diagnosed with a chronic illness or condition, such as migraine, anxiety and depression, fibromyalgia, irritable bowel syndrome, or the menopause.
During the campaign, there will be four webinars:
All webinars are free to attend.
At the end of the campaign, the BVNA will invite veterinary practices to make use of a new digital tool kit, designed to support practices to develop protocols that help veterinary nurses suffering with a chronic illness or condition.
Alex Taylor BVNA Junior Vice President said: "This campaign means a great deal to myself and the rest of the Council Members who are part of the BVNA chronic illness campaign task and finish group. Every one of us has had to deal with our own challenges as working as a veterinary nurse with a chronic illness or condition - we know how it feels and we want to help and make a real difference to people’s lives.
"As well as offering support to affected nurses, we also wanted to reach out to their colleagues, line managers and employers. We felt that having empathetic, supportive and well-informed colleagues is a key part of helping those affected by chronic illness to thrive in the workplace.
"Everyone deserves to be given the chance to reach their full potential in their job role and having a chronic illness should not be a barrier to achieving this. This campaign will not only raise awareness, but provide essential resources to those who need it, which after seeing the results of our recent survey, is very much needed."
Recordings of the webinars, the CIC toolkit, podcasts and further information will all be available to download from the BVNA website: https://bvna.org.uk
Veterinary Insights gets its data from over 400 practices using Vet Viewer, its benchmarking software which practices use to monitor business metrics.
Apparently, the figures show that while overall turnover has bounced back relatively robustly, sales in certain areas are still lagging, reflecting changed routines in the ‘new normal’. For example, with many practices requesting clients wait in the car park, there has been a sustained drop in the sale of products typically sold in the waiting room, with sales of pet food falling by 44% during early lockdown, and still down by 25% compared with February’s figures.
The company says there are also significant business stresses that may not be captured in current revenue data.
Alexander Arpino, Managing Director of Veterinary Insights, said: “Anecdotally, we’re hearing that vets are increasingly hard-pressed for time, with logistical difficulties arising from social distancing. Consults are taking longer, and there’s an additional headache for receptionists as payments have to be collected afterwards over the phone. While there are some quick fixes, for example using a telemedicine app such as LinkyVet that sets payment expectations up front, there is no doubt that it’s difficult to make all this extra time investment sustainable in the long run.”
Paradoxically, while consults may be taking up more of vets’ time, some clients feel that they are getting less value for money as there is little face-to-face interaction with the vet. Alexander added: "One of the biggest challenges in the current environment is preserving and fostering those positive relationships with clients that are the cornerstone of companion animal practice.
"Ultimately, we want to bring clients back into the consult room, but only as and when it’s safe to do so. Otherwise, the question is: How can we make adjustments to maintain a high level of client satisfaction, without putting undue stress on vets?"
Veterinary Insights says its software can help practices navigate these challenges by presenting up to 24 months of historical data extracted from practice management systems, enabling businesses to draw comparisons with past performance.
For more information, visit www.vetviewer.co.uk.
The chewable, prescription-only tablet contains sarolaner, which kills fleas and ticks; moxidectin, for the prevention of heartworm, lungworm disease and for the treatment of some intestinal worms; and pyrantel embonate, for the treatment of gastrointestinal nematodes (hookworms and roundworms).
Professor Tim Geary, BSc PhD, Professor Emeritus, Institute of Parasitology, McGill University, Canada, and Professor, School of Biological Sciences, Queen’s University, Belfast, a consultant to Zoetis, said: “Serious diseases that are preventable and of increasing prevalence threaten dogs in Canada and Europe. Simparica Trio today offers a better solution to preventing and controlling these parasites against the concern of their increasing prevalence."
Rob Kelly, President, International Operations at Zoetis said: "With Simparica Trio, we bring to market an advanced parasiticide solution, helping to deliver improved client satisfaction and patient protection.
"Thanks to its broad spectrum, Simparica Trio helps veterinarians and dog owners provide more complete parasite coverage with a single-monthly chewable tablet. The broad spectrum of Simparica Trio minimises the potential risk of parasite protection gaps."
Simparica Trio is indicated for dogs from at least eight weeks of age and 1.25 kg and will be available in six tablet strengths for dogs of all sizes.
For more information about Simparica Trio and full prescribing information, visit www.zoetis.com.
Mr Wood pleaded guilty to three charges of making indecent images of children at Portsmouth Magistrate’s Court in December 2017. Following his conviction, Mr Wood was given a community sentence, fined and made subject to a sexual harm prevention order for five years.
Mr Wood’s application for restoration was based on the argument that he was professionally competent to be restored to the Register, that he had strong mitigation for his original conviction (for which he had demonstrated remorse), that he had a low chance of reoffending, had engaged proactively with the Probation Service and rehabilitative courses, and that had completed his community service.
In considering Mr Wood’s application, the Disciplinary Committee took into account a number of factors including Mr Wood’s acceptance of the Committee’s original findings, the seriousness of the original findings, protection of the public, the future welfare of animals in his care should he be restored, the length of time off the Register, his conduct since removal from the Register, efforts by Mr Wood to keep up-to-date with his continuing professional development (CPD), the impact of removal from the Register on Mr Wood and public support for his restoration.
However, on balance, the Committee decided that Mr Wood was not currently fit to be restored to the Register.
Ian Arundale, chairing the Committee and speaking on its behalf, said: "In essence, the Committee decided that the facts of the charge justifying removal from the Register and the underlying criminal behaviour were too serious for Mr Wood to be restored at this time. It concluded that because Mr Wood continued to be subject to a sexual harm prevention order, notification requirements for sexual offenders and because he remained on the Barring List by the Disclosure and Barring service until January 2023, he was not fit to be restored to the Register at this time.
"The Committee accepted that Mr Wood had made significant efforts to rehabilitate himself but it was not persuaded that he was fit to be restored to the Register because ancillary orders relating to the underlying criminal offences remained in force. The Committee noted that at the time those orders were made Mr Wood was described as having an addiction and although the Committee accepted that there was a low risk of future reoffending, it decided that because the orders were still in place for public protection reasons, Mr Wood was not fit to be restored to the Register."
The full report of Mr Wood’s restoration hearing can be found at www.rcvs.org.uk/disciplinary
The service is being led by Isuru Gajanayake, a board-certified specialist in veterinary nutrition. He said: “Since launching our clinical nutrition service last year, we have seen a number of cases in which patients have been either dehydrated or malnourished, sometimes both.
“Working alongside our other services in a truly multidisciplinary approach, we have been able to offer suitable treatment to support a significant number of dogs and cats.
“With the launch of the parenteral nutrition service, we can now expand this offering and, in doing so, become one of only a very few referral centres across the UK to provide this as a specialist service.
“Patients who are given parenteral nutrition will be hospitalised in our advanced intensive care unit to ensure they can be monitored closely by our specialist emergency and critical care (ECC) team, who provide exceptional expertise in critical care and treatment for every patient when they need it most.
Isuru added that the addition of the clinical nutrition and parenteral nutrition services at Willows ensures that there is a much greater emphasis on nutrition and hydration for all patients at the centre, whatever their underlying illness.
For more information, visit www.willows.uk.net or search for Willows Veterinary Centre and Referral Service on Facebook.
Everyone who takes part in the survey, which is also open to vets, practice support staff and veterinary students, will be entered into a free prize draw for the chance to win a 1 of 3 Amazon gift vouchers (up to the value of £200).
Lizzie Erian-Round, Head Veterinary Healthcare Advisor at Pegasus (pictured right) said: "With lockdown measures easing, it is a good time to take a deeper dive into what the future looks like. And importantly, how veterinary professionals feel about it. No one has a crystal ball but those on the veterinary frontline are already getting a sense of what could lie ahead. And we believe it’s important they get to share their view of what good support and communications look like.
Our last wave of research indicated that COVID-19 could be a major catalyst for future digital innovation and have lasting consequences for the way we practice. With that in mind we’ve focussed our new survey to be more forward facing."
Pegasus's last survey found that 84% of veterinary professionals thought that the coronavirus pandemic would change the way veterinary practices operate in the future. 78% thought more owners will buy their medicines online. 71% worried about their exposure to coronavirus at their work place and 68% worried about the impact of the pandemic on their mental wellbeing.
The survey closes at 9am GMT Tuesday 30th June The results will help animal health companies better understand how to best support and communicate with the veterinary profession beyond the pandemic.
To take part in the survey, visit: https://www.surveymonkey.co.uk/r/DRWSNWT
For a copy of the results, which will be available in July, email: animal@thisispegasus.co.uk.
After the contamination was first identified, sales of the product in Australia were stopped immediately and Bova initiated an investigation.
The British Horseracing Authority then conducted its own analysis of samples of the UK product, discovering that it too was contaminated with testosterone.
However, Bova says the levels of testosterone in the end product were confirmed to be 400-700 pg/ml, which is less than one millionth of the internationally accepted standard for impurities (1 picogram being equal to one billionth of a milligram).
Nick Bova, managing Director of Bova UK, said: "We have consulted veterinary pharmacologists and sports medicine specialists who have given their opinion that these levels are within accepted standards and could neither have a clinical effect nor result in a positive blood or urine test for testosterone in competition horses.
"The levels of testosterone within the product are inconsequential compared to endogenous production in mares and geldings as well as stallions and higher levels are found frequently in feed and water sources; testosterone being a common compound produced by humans and animals from multiple organs."
The source of the contamination was traced to the excipient used in the product, which was used by Bova Aus and Bova UK. Both companies have now switched their supplier of this excipient. Bova says all testing done on the new supplier has shown no traces of testosterone, even with the new extra sensitive method of analysis which is capable of reaching picogram levels.
Nick added: "Whilst we hope to reassure you that the use of long acting injectable omeprazole will not have had adverse implications for your patients or clients we can also reassure you that we are not complacent about the presence of impurities in any of our products, particularly an impurity that is of such significance to equestrian sport.
"Although the level of impurities is well within the accepted international standard, we have changed the supplier of the excipient in question. We have established an analytical method capable of testing down to picogram levels, which has been used to test the end product to ensure there are no further concerns with future batches.
"We sincerely apologise for any inconvenience this issue may have caused. Many vets and horse owners now rely on long acting injectable omeprazole for horses that do not respond to oral treatment and we can reassure anyone who has used the product in recent months, or has product that they are due to use, that they can do so safely.
"However, we would draw attention to the recent statement from the BHA that they do not wish the product to be used in horses in training currently."
Visit www.bova.co.uk for further information.
Hill's Pet Nutrition has highlighted recent studies which, the company says, prove that feeding a food enriched with omega-3 fatty acids from fish oils to dogs with osteoarthritis results in a reduction in NSAID dosage of up to 25%1, owner observed improvements in clinical signs3, and improved weight bearing ability2, 7
The claim that food can effectively support medical treatment follows in the wake of two published and one in press study in the Journal of the American Veterinary Medicine Association (JAVMA). These demonstrate that omega-3 enriched food (in this case Hill's Prescription Diet j/d Canine) has significant effects on weight bearing and helps reduce NSAID dosage by up to 25 per cent, when fed to dogs with osteoarthritis 1, 2,3.
According to Hill's, the research demonstrates that in dogs the high levels of eicosapentaenoic acid (EPA) from fish oils can down-regulate the cartilage degrading enzyme aggrecanase1. In vitro studies have also identified that EPA resulted in a reduction in the amount of degraded cartilage residue produced4. High levels of omega-3 fatty acids can also help to reduce inflammation5,6.
The two studies that were recently published confirm that feeding a diet rich in omega-3 fatty acids aids in the management of osteoarthritis in dogs2,3. The randomized double-blinded controlled trials were carried out over three and six months respectively and involved a total of 165 dogs identified as suffering from mild to moderate osteoarthritis. After collating the results from almost 25,000 trial days, researchers were able to confirm a significant 'clinical improvement' from feeding a food fortified with fatty acids.
In the first study described in JAVMA, researchers found evidence that omega-3 fatty acids from fish oils resulted in improvements in weight bearing2. Objective measurement using force plate gait analysis demonstrated that dogs fed a test food fortified with fatty acids were seven times as likely to show improved weight bearing compared with dogs fed a control food.
In the second study, through a detailed questionnaire, owners also observed significant improvements in their dog's osteoarthritic condition3. Improvements observed covered the following signs: difficulty in rising from rest, limping, stiffness, soreness when touched, yelping or whimpering in pain, aggression, lagging on walks, reluctance to play and overall activity level.
Adrian Pratt, Veterinary Affairs Manager for Hill's Pet Nutrition, manufacturer of Prescription Diet j/d, which is enriched with omega-3 fatty acids, hailed the results as a breakthrough in the field of nutrigenomics (the study of the effects of nutrition on gene expression): "This research points the way to a new model for the management of osteoarthritis, using a clinically proven food to interrupt the cycle of damage and cartilage degradation, alongside graded levels of NSAIDs and proactive programmes to manage weight and adjust exercise routines. Clinicians now have the conclusive proof they need to recommend feeding omega-3 enriched food to ameliorate the signs of osteoarthritis in clients' pets and to adjust NSAID doses accordingly."
For further information on Hill's Prescription Diet j/d, please contact your Hill's Territory Manager or call 0800 282438.
References1. A multicenter study of the effect of a therapeutic food supplemented with fish oil omega-3 fatty acids on the Carpofen dosage in dogs with osteoarthritis. Fritsch A, Allen T, Dodd C, JAVMA in press2. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs. Roush J, Cross A, Renberg W, Dodd C, Sixby K, Fritsch A, Allen T, Jewell, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp67-733. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. Roush J, Dodd C, Fritsch A, Allen T, Jewell D, Schoenherr W, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp 59-664. Eicosapentaenoate supplementation abrogates canine articular cartilage degeneration in in vitro explant culture systems, Caterson B, Cramp J, Little C B et al, Hills European Symposium on osteoarthritis and joint health 2005 14-195. Dietary modification of inflammation with lipids, P C Calder, Proceedings of the Nutrition Society 2002 345-3586. Dietary polyunsaturated fatty acids and inflammatory mediator production, James M J, Cleland L G, Gibson R A, Am J Clin Nut 2000: 71 suppl 343S- 358S7. Vasseur PB, Johnson AL, Budsberg SC, et al. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. J Am Vet Med Assoc 1995; 206 (6): 807-811.
The company points to research which found that 89% of the veterinary profession wants to play a more active role in the sustainability agenda1.
For that reason, Boehringer says it put sustainability at the heart of Aservo EquiHaler, which uses no propellant gasses and the container for which is made from up to 50% recycled materials.
Now Boehringer has launched the first recycling programme for a prescription medicine in the UK to support the responsible disposal of the Aservo EquiHaler.
To join the programme, you need to visit: https://equihaler.uk/recycling, set up a TerraCycle account and register your practice. Boehringer says it only takes 10 minutes.
Once signed-up, a Boehringer Ingelheim Territory Manager will arrange for a collection box to be delivered, along with supporting practice display posters. When the box is full, there is a free pick-up service.
Practices that sign-up for the programme before 31st July 2021 will be entered into a prize draw, with the chance to win a year’s supply of ethically-sourced chocolate for their practice.
Reference:
Veterinary nurses, veterinary technicians and certain veterinary paraprofessionals around the world will soon be able to enrol for the first Distance Learning Veterinary Nurse (NCert)/ Veterinary Technician (VTCert)/Veterinary Paraprofessional (VPP) programmes.
The NCert, VTCert and VPP are due to launch in March 2021.
They each consist of eight modules, delivered using interactive online learning techniques. Delegates are guided through each module by a module tutor, while a discussion forum offers them the opportunity to share experiences and ideas with colleagues from around the world. Training in study skills and reflective practice is built into the programme to ensure that a holistic approach is taken to the learning experience.
Dr Charlotte French, Head of Curriculum and Quality at Improve International, said: “We wanted to create an exciting, practical and innovative learning experience that would offer the maximum flexibility to ambitious veterinary nurses and veterinary technicians anywhere in the world, who are keen to advance their career but need to fit their learning around their work and home responsibilities.
"We believe the modular structure and phased delivery of our programmes will offer a new level of accessibility and convenience to our delegates while giving them unique features, such as the opportunity to share their learning with colleagues from around the world and to gain support from vets and vet nurses who are specialised in their field.”
Assessment for the certificates will be undertaken by Improve’s assessment partner the International School of Veterinary Postgraduate Studies (ISVPS), and comprises:
Both examinations will be taken online with remote invigilation.
Dr Sheila Wills, Director of ISVPS, said: “Following feedback from candidates and our examiners, we have recently enhanced the examination process we offer to candidates to provide a robust assessment, while giving them the opportunity to clearly demonstrate that their learning has been understood and that they can apply it in a clinical setting.”
Further information on both programmes can be found here: https://www.improveinternational.com/uk/distance-learning-nurse/
Zenrelia is a new JAK inhibitor which Elanco says provides visible itch relief which lasts 24 hours, from the first dose.1
The company points to a head-to-head study with over 330 dogs across 25 vet clinics, in which Zenrelia was shown to get 45% more itchy dogs back to normal than Apoquel (oclacitinib).1
Elanco says its once-daily dosing may also improve treatment compliance over twice-daily alternatives.
The company also says that Zenrelia has a cost benefit too, presumably meaning it's cheaper than alternatives.
Zenrelia can be given long term with commonly used medications, including vaccines, antibiotics, parasiticides and NSAIDs.
Elanco UK & Ireland General Manager Matthew Frost said: “With this treatment, we’re looking at happier dogs and their owners, and a more rewarding experience for vets.”
www.zenrelia.co.uk
The project was launched as a joint initiative between the RCVS and the BVNA in 2016. Its objectives included highlighting veterinary nursing as a career, encouraging more people into veterinary nursing, improving retention, expanding the scope of the VN role, and providing more opportunity for career progression.
The report begins by highlighting perhaps the biggest challenge facing the profession, that in 2019, 25% of veterinary nurses said they plan to leave the profession in the next five years, largely because of poor pay, because they don't feel sufficiently valued, lack of career opportunities and because of a poor work/life balance.
The main achievements of the project, which should certainly help with some of these issues, include:
Jill Macdonald, VN Futures Project Coordinator, said: "The report is a culmination of years of hard work, putting in place measures to champion the veterinary nursing profession and safeguard it for the future. Through the introduction of initiatives like the School Ambassador Development Programme and the introduction of the CertAVN, to name but a few, we have put in place steps to inspire the next generation of veterinary nurses and support the training and development of people currently working in the profession."
You can read the full VN Futures Interim Report at https://www.vnfutures.org.uk/resource-items/vn-futures-interim-report-2021
In the 15 minute podcast, Carolyn Kyte, a vet in general practice, talks to Natalie Barnard, a veterinary dermatology specialist from Highcroft Referrals, and together they share their experience of the challenges of treating animals with otitis and explain why owners play a important role in successful treatment of the condition.
Dechra Brand Manager Carol Morgan said: “Otitis is very common, particularly in dogs, but there is no ‘quick fix’ when some underlying factors are causing the problem. This can lead to frustration for the pet’s owners and animals not getting the consistent treatment they need to get better.
“What Carolyn and Natalie bring to the table with their new podcast for the Dechra Academy is a light and insightful discussion about communication and education being the keystone for better otitis outcomes and how vets can improve on their consultation skills to handle cases better.”
The otitis podcast is here: https://academy.dechra.com/learn/course/internal/view/elearning/1034/think-differently-about-otitis
MSD says the Summer Staycation campaign is designed to support the needs of new dog owners and those taking their dogs to areas outside their local region, where parasites risks will be different.
The campaign offers veterinary practices a range of resources, including client emails, a downloadable guide to parasites, social media posts and an interactive risk checker on the Keeping Britain's Pets Healthy website. There is also some training for front of house staff and receptionists at https://www.msd-animal-health-hub.co.uk/cpd/staycation.
Nicola Barclay, Senior Product Manager at MSD Animal Health said: "Summer holidays will be taking a different form this year with most people planning trips in the UK, making it more likely they will take their pets.
"What's important is that seasoned and new owners alike are aware of the parasite risks in the places they're visiting so they aren't putting the health of their pets at risk.
"We're therefore providing a range of resources to help veterinary practices encourage pet owners to make sure there are no breaks in their parasite protection and vaccinations and that they are appropriately protected for the places they'll be visiting."
Dr Ian Wright, Head of ESCCAP UK & Ireland added: "The research findings from The Big Tick Project in 2015 found that 1 in 3 dogs coming into veterinary practices during the summer months had ticks on them.
"Research is also showing many parasites extending their range with an increased risk of human and pet exposure. Warming temperatures mean that ticks can be encountered all year round in the UK, carrying potentially dangerous pathogens to dogs and people including Lyme disease and Tick-borne encephalitis virus (TBEV).
"With so many new dog owners and people being more likely to holiday in the UK, making sure dog owners understand the risks, while keeping them in proportion, and giving appropriate protection advice is vital.''
For more information, contact your MSD Animal Health account manager.
As a result of the new partnership, customers of Bought By Many will have access to free video consultations with UK-registered veterinary surgeons via the FirstVet app.
In their blurb, the companies say that: "Many common pet health issues can be treated in the comfort of their own home, meaning owners only need to take their pet to the vet when absolutely necessary. Bought By Many customers can save time, money and potential stress to their pet by using the free FirstVet service. When a referral to a local vet is needed, FirstVet provides detailed notes of the initial consultation to both the owner and the vet."
David Prien, FirstVet’s CEO & co-founder, said: "FirstVet couldn't be more excited to offer our veterinary video consultation service together with Bought By Many in the UK.
"From our first meeting with the Bought By Many team, we knew that our values were aligned. We both share a mission to bring the best that technology has to offer both to pet owners and to the veterinary care process.
"Offering pet owners the chance to speak face-to-face with an experienced veterinarian via a video call is a great way to make sure that all pets are getting the right treatment, as fast as possible, in the right location."
For more information on Bought by Many, visit boughtbymany.com/pet-insurance.
The survey is the second stage of a three stage review recommended to RCVS Council by the College’s Standards Committee in 2019, after it looked at the implications of new technologies for both animal welfare and veterinary regulation.
The main areas under consideration include the provision of 24/7 emergency cover and the interpretation and application of an animal being under the care of a veterinary surgeon. The review also encompasses remote consulting.
In stage one of the review, the RCVS commissioned a research agency to conduct a series of focus group discussions with veterinary professionals working in a variety of roles and sectors. The information gleaned from the discussions was then used to develop the questions for this survey.
The survey will ask veterinary professionals to reflect on what, for them, should underpin good regulations and guidelines for practice.
It will then ask respondents how these principles should be applied in particular situations relating to 24/7 emergency cover and 'under care' before inviting their views on how they would like regulations on these two areas to deal with any tensions between different desirable regulatory aims.
The survey results will be used to help produce any changes to the RCVS Code of Professional Conduct and its supporting guidance concerning ‘under care’ and the provision of 24/7 emergency cover, which will then be put out for full public consultation later this year.
Chair of the RCVS Standards Committee, Dr Melissa Donald, said: “This review addresses fundamental questions about how we should continue to interpret ‘under care’ in a profession, and a society, that is largely unrecognisable to the one that first defined the term, and, at the same time, how we can continue to provide 24/7 emergency cover for those animals under our care.
“The original Vet Futures report also emphasised the impact that technological advances may have on the veterinary professions, so we must ensure we have in place a regulatory framework that gives consideration to these potential changes whilst ensuring animal health and welfare remain at its heart.
“These are challenging but hugely important questions on which we are hoping to receive as much feedback as possible. I do understand the huge pressures my vet and vet nurse colleagues continue to work under at the moment, so would like to thank them in advance for taking a little time out of their busy days to send us their views.”
The survey will open on Wednesday, 19th May 2021 for all UK-based veterinary surgeons and veterinary nurses.
All responses will be used and reported anonymously, so respondents will not be identified.
The survey will be open for four weeks, closing at 5pm on Wednesday, 16 June 2021.
It should take 15-20 minutes to complete, but can be returned to and completed in stages if preferred.
Further background information about the Under Care Review is available at www.rcvs.org.uk/undercare.